- Biogen says hello to HI-Bio, inking $1.15B buyout to expand in immunology Fierce Biotech
- Biogen to buy Human Immunology Biosciences in up to $1.8 billion deal CNBC
- Biogen acquires Hi-Bio, California biotech, for $1.15 billion The Boston Globe
- Biogen joins immunology wave with $1.15 billion acquisition of HI-Bio STAT
- Biogen Beefs Up Immuno Pipeline with Potential $1.8B HI-Bio Acquisition BioSpace
Wednesday, May 22, 2024
Biogen says hello to HI-Bio, inking $1.15B buyout to expand in immunology - Fierce Biotech
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment